ATS 2018: Interview met Dr. Marlies Wijsenbeek – Erasmus MC, Rotterdam
Diagnosis of Idiopathic Pulmonary Fibrosis – Ganesh Raghu
A2440 - Efficacy and Safety of Recombinant Human Pentraxin-2 in Patients with Idiopathic Pulmonary Fibrosis – Ganesh Raghu - JAMA
A2436 - A Randomized, Placebo-Controlled, Double Blind Phase Iia Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of 12 Weeks of Treatment of an Autotaxin Inhibitor (GLPG1690) in Individuals with Idiopathic Pulmonary Fibrosis (FLORA Trial) – Toby Maher – The Lancet Respiratory Medicine
Lees het volledige artikel
Meld u gratis aan om verder te lezen en toegang te krijgen tot alle artikelen, nascholing en accreditatie op mediamed.
Gratis aanmeldenIk heb al een Mediamed account · InloggenLees meer over:
Gerelateerde items
ERS 2024: Presentatie Marlies Wijsenbeek, ErasmusMC, Rotterdam
ERS link: Sessie 261 – Diagnosis and management of pulmonary alveolar proteinosis - European Respira ...
ERS 2024: Presentatie Thomas Koudstaal, ErasmusMC, Rotterdam
ERS link: Sessie 434 – Why is idiopathic pulmonary fibrosis not so idiopathic? Prevention of occupat ...
ERS 2023: Gizal Nakshbandi, Erasmus MC Rotterdam
OA3283 - Home spirometry in regular care for patients with pulmonary fibrosis.
ERS 2023: Video met Thomas Koudstaal, Erasmus MC Rotterdam
Session ID 240 - Pulmonary hypertension and interstitial lung diseases: dilemmas in diagnosis and th ...
